• Return to Headlines

Ocular Therapeut has the Best Relative Performance in the Pharmaceuticals Industry (OCUL , OMER , BMY , AMPH , MDCO )

By Nick Russo

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the potential to outperform.

Ocular Therapeut (NASDAQ:OCUL ) ranks first with a gain of 7.84%; Omeros Corp (NASDAQ:OMER ) ranks second with a gain of 4.48%; and Bristol-Myer Sqb (NYSE:BMY ) ranks third with a gain of 2.34%.

Amphastar Pharma (NASDAQ:AMPH ) follows with a gain of 1.16% and Medicines Comp (NASDAQ:MDCO ) rounds out the top five with a gain of 1.11%.

SmarTrend recommended that its subscribers protect gains by selling shares of Medicines Comp on September 6th, 2018 by issuing a Downtrend alert when the shares were trading at $37.27. Since that call, shares of Medicines Comp have fallen 42.1%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: relative performance ocular therapeut omeros corp bristol-myer sqb amphastar pharma medicines comp

Ticker(s): OCUL OMER BMY AMPH MDCO